Activity identification of anti-caspase-3 mRNA hammerhead ribozyme in both cell-free condition and BRL-3A cells

被引:0
|
作者
Xu, RH
Liu, J
Zhou, XQ
Xie, Q
Jin, YX [1 ]
Yu, H
Liao, D
机构
[1] Chinese Acad Sci, Shanghai Inst Biochem, State Key Lab Mol Biol, Shanghai 200031, Peoples R China
[2] Shanghai Med Univ 2, Ruijin Hosp, Dept Infect Dis, Shanghai 200025, Peoples R China
关键词
activity identification; ribozyme; BRL-3A; caspase-3; apoptosis inhibitor;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To study the transcription effects and cleavage activities of rat caspase-3 specific hammerhead ribozyme (Rz107) in both cell-free conditions and BRL-SA cells. Methods Rat caspase-3 gene fragment was cloned into the pGEM-T EASY vector under the T7 promoter control. The (32P)-labeled caspase-3 transcript was the target-RNA. Rz107 genes designed against caspase-3 mRNA were cloned into vector p1.5 between 5'-cis-Rz and 3'-cis-Rz. P-32-labeled ribozyme transcripts were incubated with target-RNAs at different conditions and autoradiographed after denaturing gel-electrophoresis. Rz107 was electroporated into BRL-3A cells and the Rz107 expression was analyzed by RT- PCR. Results In cell-free conditions, Rz107 was active at 37 degrees3. The optimal temperature was 50 degreesC. The K, and k(cat) were 14.13 nmol/L and 2.31 min(-1) respectively. Intracellular cleavage efficiency of Rz107 was 37%, as analyzed by RT-PCR. This indicated that the design of Rz107 was correct, and Rz107 had the activity of common enzymes. Conclusions Rz107 in cell-free conditions possessed perfect specific catalytic cleavage activity, and it can also cleave the target RNA successfully in cells. The results illustrate the feasibility of ribozyme therapy as a potential alternative approach for treating liver disease caused by apoptosis.
引用
收藏
页码:606 / 611
页数:6
相关论文
共 16 条
  • [1] Human ICE/CED-3 protease nomenclature
    Alnemri, ES
    Livingston, DJ
    Nicholson, DW
    Salvesen, G
    Thornberry, NA
    Wong, WW
    Yuan, JY
    [J]. CELL, 1996, 87 (02) : 171 - 171
  • [2] BETTRAND E, 1994, NUCLEIC ACIDS RES, V22, P293
  • [3] Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways
    Bohlinger, I
    Leist, M
    Barsig, J
    Uhlig, S
    Tiegs, G
    Wendel, A
    [J]. HEPATOLOGY, 1995, 22 (06) : 1829 - 1837
  • [4] RIBOZYME CLEAVES REX TAX MESSENGER-RNA AND INHIBITS BOVINE LEUKEMIA-VIRUS EXPRESSION
    CANTOR, GH
    MCELWAIN, TF
    BIRKEBAK, TA
    PALMER, GH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) : 10932 - 10936
  • [5] DEZHONG L, 1999, ASIAN J ANDROL, V1, P195
  • [6] Caspase inhibitors
    Ekert, PG
    Silke, J
    Vaux, DL
    [J]. CELL DEATH AND DIFFERENTIATION, 1999, 6 (11): : 1081 - 1086
  • [7] Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
    Enari, M
    Talanian, RV
    Wong, WW
    Nagata, S
    [J]. NATURE, 1996, 380 (6576) : 723 - 726
  • [8] A HAMMERHEAD RIBOZYME INHIBITS ADE1 GENE-EXPRESSION IN YEAST
    FERBEYRE, G
    BRATTY, J
    CHEN, H
    CEDERGREN, R
    [J]. GENE, 1995, 155 (01) : 45 - 50
  • [9] Processing/activation of CPP32-like proteases is involved in transforming growth factor beta(1)-induced apoptosis in rat hepatocytes
    InayatHussain, SH
    Couet, C
    Cohen, GM
    Cain, K
    [J]. HEPATOLOGY, 1997, 25 (06) : 1516 - 1526
  • [10] Jaeschke H, 1998, J IMMUNOL, V160, P3480